Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.24.1.1.u2
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ in Thousands
 3 Months Ended
Dec. 27, 2023
USD ($)
Jan. 26, 2023
USD ($)
shares
Mar. 31, 2024
USD ($)
item
shares
Dec. 31, 2023
USD ($)
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS        
Number of branded drugs in product portfolio | item     7  
Number of authorized generic prescription drugs | item     2  
Cash and cash equivalents     $ 24,057 $ 27,439
Stock issued value     1,484  
Proceeds from issuance of common stock     $ 1,484  
Common Stock        
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS        
Stock issued value   $ 150,000    
Stock issued (in shares) | shares   4,900,000 289,744  
Proceeds from issuance of common stock     $ 1,500  
Common Stock | Employee severance obligation        
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS        
Number of shares available for issuance | shares     3,861,553  
Term loan | East West Bank        
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS        
Maximum borrowing capacity $ 20,000      
Proceeds from term-loan 15,000      
Remaining borrowing capacity $ 5,000